
Loading, please wait...

Loading, please wait...

Physicians often find it difficult to predict when a patient with a brain bleed will worsen within the first day of admission. Specifically, a recent retrospective analysis clarifies how supratentorial ICH hematoma volume predicts early neurological deterioration (END) based on anatomical location. Researchers analyzed data from nearly 1,200 patients across three separate cohorts. They found that different brain regions have unique tolerance levels for blood volume. Consequently, they developed the LIVED score to provide a more precise risk assessment during the critical first 24 hours of admission.
The study highlights that the hemorrhage location significantly dictates the risk of clinical decline. For instance, the threshold for END is just 12 mL in the thalamus. However, lobar hemorrhages require a much larger volume of 32 mL to cause similar neurological decline. Furthermore, basal ganglia bleeds show a critical cutoff at 21 mL. Therefore, clinicians must assess volume in the context of location rather than using a universal threshold. This anatomical nuance ensures that high-risk patients receive more intensive monitoring and timely intervention.
Moreover, the multivariable analysis identified four independent predictors for the LIVED score. These factors include location-specific volume, right-sided ICH, prior ischemic stroke, and the admission NIHSS score. This scoring system ranges from zero to five points. Notably, the score outperformed the traditional ICH score in predicting both short-term deterioration and three-month functional recovery. Consequently, it offers a robust tool for clinical decision-making and patient counseling in acute stroke units.
Integrating location-specific thresholds into routine care may refine how neurologists triage supratentorial ICH. While traditional scores provide a general prognosis, the LIVED score targets the specific risk of early deterioration. Additionally, the score demonstrated strong discrimination for functional independence and mortality at 90 days. This makes it a valuable asset for long-term outcome prediction. Therefore, adopting this localized approach could improve the precision of stroke management in emergency settings.
The study identified specific thresholds for early deterioration: 12 mL for the thalamus, 21 mL for the basal ganglia, and 32 mL for lobar hemorrhages.
The LIVED score includes location-specific hematoma volume, right-sided ICH, history of prior ischemic stroke, and the admission National Institutes of Health Stroke Scale (NIHSS) score.
The LIVED score showed superior predictive performance for early neurological deterioration compared to established ICH scores across all study cohorts.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Li Z et al. Location-Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH. Ann Clin Transl Neurol. 2026 Feb 22. doi: 10.1002/acn3.70351. PMID: 41725025.
Greenberg SM, et al. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2022;53(7):e282-e361.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Study identifies location-specific hematoma volume cutoffs and the LIVED score to predict early neurological deterioration in supratentorial ICH patients....
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today